A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
Authors
Keywords
-
Journal
Science Immunology
Volume 7, Issue 67, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-01-08
DOI
10.1126/sciimmunol.abi6899
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
- (2021) Giulia Agliardi et al. Nature Communications
- OSskcm: an online survival analysis webserver for skin cutaneous melanoma based on 1085 transcriptomic profiles
- (2020) Lu Zhang et al. Cancer Cell International
- Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
- (2020) Wentao Kuai et al. Biomed Research International
- Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
- (2020) Aslan Mansurov et al. Nature Biomedical Engineering
- Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
- (2019) Zhida Liu et al. Science Immunology
- Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
- (2019) Karen A. Autio et al. CLINICAL CANCER RESEARCH
- A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
- (2019) Zhichen Sun et al. Nature Communications
- OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts
- (2019) Zhongyi Yan et al. Frontiers in Oncology
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
- (2018) Magdalena Jarosz-Biej et al. PLoS One
- PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer
- (2018) Michitaka Nakano et al. CANCER SCIENCE
- Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
- (2018) Chien-Chun Steven Pai et al. JOURNAL OF CLINICAL INVESTIGATION
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
- (2017) Zhong-Yi Dong et al. OncoImmunology
- Tim-3 Expression on Tumor-Infiltrating PD-1 + CD8 + T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
- (2016) Clémence Granier et al. CANCER RESEARCH
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunocytokine NHS-IL12 as a potential cancer therapeutic
- (2015) Jonathan Fallon et al. Oncotarget
- Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
- (2014) H. R. Ali et al. ANNALS OF ONCOLOGY
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Immunoexpression of Metalloproteinases 2 and 14 and TIMP-2 Inhibitor in Main Types of Primary Gastric Carcinomas and Lymph Node Metastasis
- (2014) Daniel Cordeiro Gurgel et al. PATHOLOGY & ONCOLOGY RESEARCH
- Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
- (2013) L. R. Desnoyers et al. Science Translational Medicine
- The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
- (2012) N. Pasche et al. CLINICAL CANCER RESEARCH
- Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases
- (2012) Oran Erster et al. JOURNAL OF CONTROLLED RELEASE
- Ex Vivo Interleukin-12-Priming During CD8+ T Cell Activation Dramatically Improves Adoptive T Cell Transfer Antitumor Efficacy in a Lymphodepleted Host
- (2012) Mark P. Rubinstein et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model
- (2012) Bang-Wen Xie et al. PLoS One
- Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases
- (2011) John Puskas et al. IMMUNOLOGY
- The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis
- (2011) Catherine E. Steding et al. IMMUNOLOGY
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer
- (2010) María Fernanda García et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments
- (2009) Michelle R. Simpson-Abelson et al. CLINICAL IMMUNOLOGY
- Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
- (2008) P. M. McGowan et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now